Q5E-15427-42473
2 vaccinations
2 coded responses
6 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 919 / CA
- Registered
- 2021-07-28
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-07-06
Dose 1 — Pfizer-BioNTech
-
2021-07-27
Dose 2 — Pfizer-BioNTech
-
2021-07-28
Registered in v-safe
-
2021-07-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-07-29
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Poor · Site: Redness, Swelling · Headache, Nausea · Be unable to work or attend schoolFree text: DizzinessMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-30
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain, Swelling · HeadacheFree text: DizzinessMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-04
- 2021-08-24
- 2021-08-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-06 | Pfizer-BioNTech | No |
| 2 | 2021-07-27 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Systemic reaction (other): Dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release